II Editor
18 Jan 2016
NEW ARTICLE: Viewpoint: The outlook for UK equities "March saw an improved outlook for economic growth in the UK but it was not matched by an associated uplift in the earnings forecasts for companies.The UK stockmarket concluded the first quarter of 2014 in negative territory, despite the improving ..."[link]
II Editor
18 Dec 2015
NEW ARTICLE: Share of the week: Circassia shares on steroids "Allergy drugs group LSE:CIR:Circassia Pharmaceuticals has been under the weather for the past few months, ever since investors lost faith in its ability to turn a promising pipeline into profits. But that faith, it seems, has returned in ..."[link]
gamesinvestor
26 Nov 2015
Market response Looks like it didn't respond to the announcement yesterday, but did this morning, up 2.92%Games -- Have I timed one right for a change?
gamesinvestor
25 Nov 2015
Re: Bought "Woody is a CIR fan"LK --- Agggh no he's not is he?Ruined my coffee morning now -- I might have to consider offloading it then.Games -- poor old Woody, although he got a bit of a lift with Babcock yesterday -- I didn't though because I don't own it -- and probably won't!!
LK Hyman
25 Nov 2015
Re: Bought Games,Welcome on board! As a GSK holder as well as a CIR holder I was in two minds about CIR's tab displacing GSK's.Woody is a CIR fan but, nevertheless, I feel that its clear and specific focus on allergies and, specifically, allergies that affect a lot of people merits a buy.LKH on the flybridge
gamesinvestor
25 Nov 2015
Bought In for the first time.278 entry --- for the long term I assume.Let's hope they can dislodge some of GSK's market share, especially since lightening my load on GSK itself, the lumbering giant that it has become.Games
gamesinvestor
24 Nov 2015
Re: Asmtha cat attack!!!! Oh I do apologise I had a sneezing attack as I started typing.It must have been net door's cat.I meant to type Asthma not Asmtha!!Games
gamesinvestor
24 Nov 2015
Asmtha cat attack!!!! [link] - So does this mean I should buy into this moggy affair?Games
dave31
30 Aug 2015
Moving Up Seems to be finally getting somewhere. Anyone have any insight as to what is driving this?Dave
dokp
01 Jun 2015
Re: Options I bought these on the basis they were developing allergy treatments and if successful the SP would leap manyfold. Buying other companies suggests to me that they are not so sure about the prospects for their own treatments so are buying other companies who are similarly not so sure otherwise wouldn't be selling. I suppose it diversifies specific risk but it was the specific risk I was buying.
dave31
31 May 2015
Options Question: Should I take up my options now that the share price is below the option price or should I leave it? Can anyone explain why the share price dropped as soon as the acquisitions were announced? Does the market not like what Circassia is doing? Dave
Cream Walker
07 May 2015
Investment Encouraging that Neil Woodford has included a considerable investment in Circassia in his new Investment trust.
LK Hyman
22 Mar 2015
Re: Odey on board LEA,"Odey have spotted the potential"So has Woody Woodford. And (this is the clincher) so hasLKH on the flybridge in deep
LEA SERP
23 Jan 2015
Odey on board Surprised not more interest in this exciting allergy treatment developer which raised £200m in its initial public offering in March 2104.The biotech firm, which was spun out of university technology transfer group Imperial Innovations, priced its flotation at the upper end of its price range at 310p per share, but the sp has fallen back on the lack of news.Circassia's main products include treatments for cat allergy and similar products for house dust mites and hayfever, all allergy immunotherapy products that are designed to overcome the limitations of current treatments.Odey have spotted the potential 10x upside in the share price and added CIR to their highly successful Absolute Return Fund. If it's good enough for them, it's good enough for me.AIMOO, DYOR etc
